미국의 신장 보존 시장 규모, 점유율, 동향 분석 보고서 : 보존 용액별, 기술별, 기증자 유형별, 최종 용도별, 부문 예측(2025-2030년)

U.S. Kidney Preservation Market Trends:

The U.S. kidney preservation market size was estimated at USD 21.2 million in 2024 and is expected to grow at a CAGR of 6.97% from 2025 to 2030. The market growth is driven by several factors, including the rising incidence of end-stage renal disease (ESRD) and chronic conditions such as diabetes and hypertension. The increasing demand for kidney transplants also fuels market growth. Advances in preservation technologies, such as normothermic machine perfusion, enhance organ viability during transportation and storage. Government initiatives supporting organ donation programs further boost the market.

A major driver of the U.S. kidney preservation market's expansion is the consistent rise in deceased donor transplants, which has led to a greater need for reliable preservation solutions. For instance, according to the Organ Procurement & Transplantation Network (OPTN), the deceased donor transplants in the U.S. increased from 12,279 in 2014 to 22,074 in 2024. According to recent trends, the number of deceased donors has increased due to a combination of opioid-related deaths and expanded donor acceptance criteria. As organ procurement organizations (OPOs) prioritize the recovery of kidneys from donors with varying physiological profiles, including those with AKI or comorbidities, reliance on advanced preservation becomes critical to optimize transplant outcomes. Additionally, the 2021 shift to a distance-based kidney allocation policy by UNOS has increased the geographic radius of organ distribution, further intensifying the importance of extended preservation techniques.

Similarly, the number of kidney transplants in the U.S. is witnessing a significant surge, which is expected to continue over the forecast period, thereby increasing the demand for advanced kidney preservation solutions.

Moreover, the growth of the U.S. kidney preservation market is also driven by a rise in government and organizational initiatives aimed at boosting kidney donation rates. Federal programs such as the Advancing American Kidney Health Initiative and policy reforms by the Centers for Medicare & Medicaid Services (CMS) have prioritized expanding access to transplantation by incentivizing organ procurement organizations (OPOs) to increase recovery and utilization of viable kidneys.

In 2024, the Gift of Life Donor Program led U.S. organ procurement organizations by coordinating 947 kidney transplants, marking its ninth consecutive year at the forefront. Celebrating its 50th anniversary, the Philadelphia-based organization has facilitated over 21,000 kidney transplants. Such initiatives by various organizations are further expected to increase the number of kidney donations in the country, thereby driving demand for preservation solutions over the forecast period.

U.S. Kidney Preservation Market Report Segmentation

This report forecasts revenue growth at the country level and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. kidney preservation market report based on preservation solution, technique, donor type, and end use.

• Preservation Solution Outlook (Revenue, USD Million, 2018 - 2030)
• University of Wisconsin (UW)
• Histidine-Tryptophan-Ketoglutarate (HTK) Solution
• Celsior Solution
• Hypertonic Citrate Adenine (HC-A) Solution
• Institute Georges Lopez (IGL-1) Solution
• Others
• Technique Outlook (Revenue, USD Million, 2018 - 2030)
• Static Cold Storage
• Hypothermic Machine Perfusion
• Normothermic Machine Perfusion
• Other
• Donor Type Outlook (Revenue, USD Million, 2018 - 2030)
• Standard Criteria Donor (SCD)
• Expanded Criteria Donor (ECD)
• Donation after Brain Death (DBD)
• Donation after Circulatory Death (DCD)
• Living Donor
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Transplant Centers / Hospitals
• Organ Procurement Organizations (OPOs)
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Preservation Solution Segment
  • 1.2.2. Technique Segment
  • 1.2.3. Donor Type Segment
  • 1.2.4. End Use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. U.S. Kidney Preservation Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of kidney diseases
    • 3.2.1.2. Growing kidney donations and transplants
    • 3.2.1.3. Growing geriatric population
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of kidney transplantation
• 3.3. Kidney Preservation Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Kidney Preservation Market: Preservation Solution Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Kidney Preservation Market Preservation Solution Movement Analysis
• 4.3. U.S. Kidney Preservation Market Size & Trend Analysis, by Preservation Solution, 2018 to 2030 (USD Million)
• 4.4. University of Wisconsin (UW)
  • 4.4.1. University of Wisconsin (UW) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 4.5. Histidine-Tryptophan-Ketoglutarate (HTK) Solution
  • 4.5.1. Histidine-Tryptophan-Ketoglutarate (HTK) solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 4.6. Celsior Solution
  • 4.6.1. Celsior Solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 4.7. Hypertonic Citrate Adenine (HC-A) Solution
  • 4.7.1. Hypertonic Citrate Adenine (HC-A) solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 4.8. Institute Georges Lopez (IGL-1) Solution
  • 4.8.1. Institute Georges Lopez (IGL-1) solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 4.9. Others
  • 4.9.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Kidney Preservation Market: Technique Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Kidney Preservation Market Technique Movement Analysis
• 5.3. U.S. Kidney Preservation Market Size & Trend Analysis, by Technique, 2018 to 2030 (USD Million)
• 5.4. Static Cold Storage
  • 5.4.1. Static cold storage market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 5.5. Hypothermic Machine Perfusion
  • 5.5.1. Hypothermic machine perfusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 5.6. Normothermic Machine Perfusion
  • 5.6.1. Normothermic machine perfusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Kidney Preservation Market: Donor Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Kidney Preservation Market Donor Type Movement Analysis
• 6.3. U.S. Kidney Preservation Market Size & Trend Analysis, by Donor Type, 2018 to 2030 (USD Million)
• 6.4. Standard Criteria Donor (SCD)
  • 6.4.1. Standard Criteria Donor (SCD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. Expanded Criteria Donor (ECD)
  • 6.5.1. Expanded Criteria Donor (ECD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 6.6. Donation after Brain Death (DBD)
  • 6.6.1. Donation after Brain Death (DBD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 6.7. Donation after Circulatory Death (DCD)
  • 6.7.1. Donation after Circulatory Death (DCD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 6.8. Living Donor
  • 6.8.1. Living donor market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Kidney Preservation Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. U.S. Kidney Preservation Market End Use Movement Analysis
• 7.3. U.S. Kidney Preservation Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Transplant Centers / Hospitals
  • 7.4.1. Transplant centers / Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Organ Procurement Organizations (OPOs)
  • 7.5.1. Organ Procurement Organizations (OPOs) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. TransMedics Inc.
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. XVIVO
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Bridge to Life Ltd.
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Paragonix Technologies Inc.
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. OrganOx Limited
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Organ Recovery Systems
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Institut Georges Lopez (IGL)
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Preservation Solutions, Inc.
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Global Transplant Solutions
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Essential Pharmaceuticals LLC
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives